Road User Exposure from ITS-5.9 GHz Vehicular Connectivity.

RF dose assessment RF exposure V2X road user vehicular connectivity

Journal

Sensors (Basel, Switzerland)
ISSN: 1424-8220
Titre abrégé: Sensors (Basel)
Pays: Switzerland
ID NLM: 101204366

Informations de publication

Date de publication:
15 Sep 2022
Historique:
received: 27 07 2022
revised: 08 09 2022
accepted: 13 09 2022
entrez: 23 9 2022
pubmed: 24 9 2022
medline: 28 9 2022
Statut: epublish

Résumé

This study addressed an important but not yet thoroughly investigated topic regarding human exposure to radio-frequency electromagnetic fields (RF-EMF) generated by vehicular connectivity. In particular, the study assessed, by means of computational dosimetry, the RF-EMF exposure in road users near a car equipped with vehicle-to-vehicle (V2V) communication antennas. The exposure scenario consisted of a 3D numerical model of a car with two V2V antennas, each fed with 1 W, operating at 5.9 GHz and an adult human model to simulate the road user near the car. The RF-EMF dose absorbed by the human model was calculated as the specific absorption rate (SAR), that is, the RF-EMF power absorbed per unit of mass. The highest SAR was observed in the skin of the head (34.7 mW/kg) and in the eyes (15 mW/kg); the SAR at the torso (including the genitals) and limbs was negligible or much lower than in the head and eyes. The SAR over the whole body was 0.19 mW/kg. The SAR was always well below the limits of human exposure in the 100 kHz-6 GHz band established by the International Commission on Non-Ionizing Radiation Protection (ICNIRP). The proposed approach can be generalized to assess RF-EMF exposure in different conditions by varying the montage/number of V2V antennas and considering human models of different ages.

Identifiants

pubmed: 36146331
pii: s22186986
doi: 10.3390/s22186986
pmc: PMC9500951
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : French Agency for Food, Environmental and Occupational Health & Safety
ID : PNREST Anses 2020/2 RF/05

Références

Phys Med Biol. 1996 Nov;41(11):2251-69
pubmed: 8938025
Health Phys. 2016 Dec;111(6):528-541
pubmed: 27798477
Phys Med Biol. 2014 Aug 21;59(16):4739-47
pubmed: 25082800
Health Phys. 2020 May;118(5):483-524
pubmed: 32167495
Annu Int Conf IEEE Eng Med Biol Soc. 2019 Jul;2019:6910-6913
pubmed: 31947428
Int J Environ Res Public Health. 2019 Apr 06;16(7):
pubmed: 30959870

Auteurs

Martina Benini (M)

Department of Electronics, Information and Bioengineering (DEIB), Politecnico di Milano, 20133 Milan, Italy.
Institute of Electronics, Computer and Telecommunication Engineering (IEIIT), Consiglio Nazionale delle Ricerche (CNR), 20133 Milano, Italy.

Marta Parazzini (M)

Institute of Electronics, Computer and Telecommunication Engineering (IEIIT), Consiglio Nazionale delle Ricerche (CNR), 20133 Milano, Italy.

Marta Bonato (M)

Institute of Electronics, Computer and Telecommunication Engineering (IEIIT), Consiglio Nazionale delle Ricerche (CNR), 20133 Milano, Italy.

Silvia Gallucci (S)

Department of Electronics, Information and Bioengineering (DEIB), Politecnico di Milano, 20133 Milan, Italy.
Institute of Electronics, Computer and Telecommunication Engineering (IEIIT), Consiglio Nazionale delle Ricerche (CNR), 20133 Milano, Italy.

Emma Chiaramello (E)

Institute of Electronics, Computer and Telecommunication Engineering (IEIIT), Consiglio Nazionale delle Ricerche (CNR), 20133 Milano, Italy.

Serena Fiocchi (S)

Institute of Electronics, Computer and Telecommunication Engineering (IEIIT), Consiglio Nazionale delle Ricerche (CNR), 20133 Milano, Italy.

Gabriella Tognola (G)

Institute of Electronics, Computer and Telecommunication Engineering (IEIIT), Consiglio Nazionale delle Ricerche (CNR), 20133 Milano, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH